Click here to view next page of this article

 

Changing Concepts in Endometrial Carcinoma

Introduction

No conclusive, prospective randomized trials clearly offer definitive guidelines.

Many questions remain

When is lymph node sampling helpful?

What is the value of postoperative radiation?

 What is the value of adjunctive chemotherapy?

What is the role of hormone therapy?

Which chemotherapeutic agents are active?

Epidemiology And Risk

Incidence: 2006 American Cancer Society projections

Most common gynecologic cancer (after breast)

Third: colorectal (66,000)

Fourth: endometrial (4,000)

B. Distribution by stage: International Federation of Gynecology and Obstetrics

FIGO Staging

Stage I: 75%

Stage II: 15%

Stage III: 7%

Stage IV: 3%

Estimate of risk

Geographic: the white population in the United States has the highest age-adjusted incidence in the world

Race: United States

White peak: 87% in 100,000 at 65-70 years

Black peak: 78 % in 100,000 at 75-80 years

3. Age

Postmenopausal: 75-80%

Mean age at diagnosis: 61 years

<5 % below age 40

4. Obesity

From 20-50 lbs overweight: 3X

Over 50 lbs overweight: 9X

Diabetes: up to 3X increased risk

Hypertension

Parity

One-third nulliparous

Risk decreases with